News
News Update
Business Wire
Press Releases
Economy
Business Life
Opinion
Legal Center
Classifieds
Executive Calendar
Networking Calendar
Subscribe
Archives
Contact Us
Links
Media Kit
Home



Press Releases
Search:

Clinical Trials & Medical Discoveries Headlines from PR Newswire


< Go Back

New indication for VIMPAT® (lacosamide): UCB's anti-epileptic drug approved by FDA as monotherapy in the treatment of patients with partial-onset seizures
Daiichi Sankyo Further Expands TaNeDS Collaborative Drug Discovery Program in Europe
Sanofi and Regeneron Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
Regeneron and Sanofi Announce Presentation of Detailed Positive Results from Four Pivotal Alirocumab Trials at ESC Congress 2014
China Human Vaccine Industry (Hepatitis B, Influenza, Rabies & Pneumonia) 2017 Forecasts
Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial
Novartis' new heart failure medicine LCZ696 cut cardiovascular deaths by 20% vs. ACE-inhibitor in landmark PARADIGM-HF trial
Boston Scientific Study Published In Gastroenterology Reports Successful Management Of Benign Biliary Strictures With Fully Covered Metal Stents
Pfenex Reports Second Quarter 2014 Results and Provides Business Update
Mast Therapeutics Announces Management Change
Janssen Expands EXPLORER Global Cardiovascular Research Program to Evaluate the Role of XARELTO® in Addressing Critical Medical Needs
DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments
Enrollment in Pharmatech's Revolutionary AccessPPM Program Launches
Takeda Announces Completion of the Post-Marketing Commitment to Submit Data to the FDA, the EMA and the PMDA for Pioglitazone Containing Medicines Including ACTOS
BloodCenter of Wisconsin Launches Erythroid Chimerism Test for Monitoring Transplanted Sickle Cell Disease Patients
Texas Children's Hospital launches immunotherapy study
Seres Health to Present Clinical Findings at ICAAC 2014 Conference
Telik Reports Progress Toward Multiple Early Stage Milestones in the Development of a Novel Antibody-based Therapeutic Agent for Gastrointestinal Cancers
Amgen Announces Positive Top-Line Results From Phase 3 YUKAWA-2 Trial Of Evolocumab In Combination With Statins In Japanese Patients With High Cardiovascular Risk And High Cholesterol
Amgen Submits Biologics License Application For Novel Investigational LDL Cholesterol-Lowering Medication Evolocumab To The FDA
Sequent Medical Announces Initiation Of IDE Study For The WEB Aneurysm Embolization System
The Leukemia & Lymphoma Society Provides Equity Financing to OncoPep to Support Clinical Trial for Myeloma Vaccine
EnteroMedics Announces Three Year Diabetes, Hypertension and Weight Loss Data from the Maestro® RC System DM2 ENABLE Study
Isis Pharmaceuticals Initiates Phase 3 Study of ISIS-APOCIII Rx in Patients with FCS
Synthetic Biologics and FUJIFILM Diosynth Biotechnologies UK Announce Significant Improvement in API Manufacturing of SYN-004 for the Prevention of C. difficile
Auxilium Pharmaceuticals, Inc. To Present CCH Data For Concurrent Treatment Of Multiple Dupuytren's Cords At ASSH Annual Meeting
IBM Watson Ushers in a New Era of Data-Driven Discoveries
Heart Hospital of Austin First in Texas to Implant New Portico™ Re-sheathable Transcatheter Aortic Valve System as Part of Clinical Trial
DelMar Pharmaceuticals To Present At The 16th Annual Rodman & Renshaw Global Investment Conference
Surgery to repair a hip fracture reduces lifetime health care costs by more than $65,000 per patient, adds years of patient life quality and mobility
Novel Biomarker Detects Early Rheumatoid Arthritis Better than Conventional Methods Alone, According to Journal of Rheumatology Study
FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure
Report: Companion Testing Market Exceeded One Billion Dollars in 2013
Mers CoV Virus Gene Replikins Found Conserved and Shared in Current Strains Back to 2012 English
Dengue Virus Gene Replikins Found Conserved and Shared in Current Dengue Strains Back to 1944
Twelve UK Hospitals Enjoy Reduced Surgical Procedure Times and Decline in Costs by Implementing Stratasys 3D Printing Solutions
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder
FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database English
Profil Institute Reaches Milestone in Early Phase Clinical Research for Diabetes
Ruthigen Receives Recommendation from Data Monitoring Committee to Initiate Phase 1/2 Human Clinical Trial of RUT58-60
Study Results Using OncoE6™ Oral and Cervical Tests
Spring Bioscience launches highly sensitive PD-L1 (SP142) antibody for immunotherapy research English
Alzheimer's Prevention Registry Reaches Recruitment Milestone of 40,000 Individuals
Clinical Results Presented for Trovagene's Urine-Based High-Risk HPV Assay. English
Data on XARELTO® at ESC Congress 2014 Hot Line Session Premieres First Prospective Study of a Factor Xa Inhibitor in Elective Cardioversion
Letter to the Ampio Shareholders in Regard to the STEP Study and Ampio's plans for the Ampion™ BLA
U.S. Army Funds Phase II Clinical Trial at UCLA for the Treatment of PTSD with the NeuroSigma eTNS System
Regado Biosciences Permanently Halts REGULATE-PCI Clinical Trial
BioLife Solutions CryoStor® AND HypoThermosol® Now Embedded In 130 Regenerative Medicine Clinical Trials English
Regeneron and Sanofi to Present Results from Four Phase 3 Alirocumab Trials in Hot Line Session at ESC Congress 2014

< Prev Next >
PR Newswire - United Business Media


Search Classifieds:


Copyright © , Las Vegas Business Press